IRIS
IEZZI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.701
EU - Europa 1.499
AS - Asia 940
SA - Sud America 115
AF - Africa 17
OC - Oceania 1
Totale 4.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.676
RU - Federazione Russa 753
SG - Singapore 372
CN - Cina 253
IE - Irlanda 129
IT - Italia 122
VN - Vietnam 116
SE - Svezia 110
DE - Germania 101
BR - Brasile 83
FR - Francia 80
UA - Ucraina 75
TR - Turchia 72
GB - Regno Unito 55
IN - India 36
HK - Hong Kong 33
AT - Austria 15
AR - Argentina 13
FI - Finlandia 12
CA - Canada 10
CZ - Repubblica Ceca 10
MX - Messico 10
BD - Bangladesh 9
IQ - Iraq 9
JP - Giappone 8
PL - Polonia 8
ZA - Sudafrica 7
ES - Italia 6
CL - Cile 5
PY - Paraguay 5
RO - Romania 5
SA - Arabia Saudita 5
BE - Belgio 4
LB - Libano 4
LT - Lituania 4
NL - Olanda 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
JO - Giordania 3
KE - Kenya 3
BO - Bolivia 2
ET - Etiopia 2
KR - Corea 2
OM - Oman 2
PH - Filippine 2
PK - Pakistan 2
PT - Portogallo 2
TN - Tunisia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KW - Kuwait 1
MA - Marocco 1
NI - Nicaragua 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.273
Salva come PNG Salva come JPEG
Città #
Singapore 310
Chandler 238
San Jose 203
Ashburn 147
Dublin 128
Jacksonville 127
Dearborn 90
Beijing 73
Houston 59
Dallas 58
Los Angeles 53
Princeton 52
Munich 43
Izmir 41
Nanjing 39
Ho Chi Minh City 37
Hong Kong 32
Wilmington 29
New York 28
Santa Clara 27
Altamura 26
Chieti 26
The Dalles 25
Ann Arbor 21
Boardman 20
Dong Ket 20
Hanoi 18
Council Bluffs 17
Southend 16
Moscow 15
Orem 14
Cambridge 13
Kunming 13
São Paulo 13
London 12
Redondo Beach 12
Nanchang 10
Nuremberg 10
Washington 10
Atlanta 9
Brno 9
Pescara 9
Shenyang 9
St Louis 9
Brooklyn 8
Chicago 8
Denver 8
Frankfurt am Main 8
Stockholm 8
Vienna 8
Buffalo 7
Jiaxing 7
Montreal 7
Norwalk 7
Tokyo 7
Warsaw 7
Da Nang 6
Hefei 6
Mexico City 6
Tianjin 6
Boston 5
Hebei 5
Helsinki 5
Johannesburg 5
Mumbai 5
Brussels 4
Chennai 4
Haiphong 4
Hyderabad 4
Manchester 4
Poplar 4
San Francisco 4
Tongling 4
Woodbridge 4
Zhengzhou 4
Amman 3
Amsterdam 3
Asunción 3
Falls Church 3
Hangzhou 3
Istanbul 3
Joinville 3
Miami 3
Perego 3
Phoenix 3
Pune 3
Querétaro 3
Rio de Janeiro 3
Rome 3
Savigliano 3
Secaucus 3
Tappahannock 3
Tashkent 3
Addis Ababa 2
Baghdad 2
Campinas 2
Cerveteri 2
Changsha 2
Charlotte 2
City of London 2
Totale 2.417
Salva come PNG Salva come JPEG
Nome #
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 863
Impact of BMI on clinical outcome in advanced cancer patients treated with anti‑PD‑1 Immune checkpoint inhibitors: a preliminary analysis 178
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience 174
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 167
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients 165
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin 161
A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression 159
Trastuzumab Emtansine (T-DM1) in Patients (pts) With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC): results From a Multicenter Retrospective Analysis 154
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 148
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials 146
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study 136
Fulvestrant (FUL) 500 milligrams as endocrine therapy (ET) for hormone sensitive advanced breast cancer patients (pts). The Ful500 prospective observational trial 136
Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting 135
Long-term outcome of neoadjuvant endocrine therapy with aromatase inhibitors in elderly women with hormone receptor-positive breast cancer 133
Fulvestrant 500 milligrams as endocrine therapy for endocrine sensitive advanced breast cancer patients in the real world: the Ful500 prospective observational trial. 131
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 126
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study 125
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 125
Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage? Reply to Kadri Altundag 124
Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study 124
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 123
Predictive factors of response to neoadjuvant chemotherapy (NAT) in triple negative breast (TNBC) cancer patients: A restrospective multicenter observational study. 122
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience 118
Long-term outcome of breast cancer patients with pathologic N3a lymph node stage 117
Triple positive early breast cancer in the pre- and post Trastuzumab eras: a subgroup analysis of a multicenter retrospective study. 110
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting 94
Prognostic relevance of DNA damage and repair biomarkers in elderly patients with hormone-receptor-positive breast cancer treated with neoadjuvant hormone therapy: evidence from the real-world setting 92
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 79
Totale 4.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.343
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.343
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 0 28
2021/2022142 0 6 0 33 6 4 6 8 9 4 15 51
2022/2023561 38 75 38 77 48 100 22 55 69 7 21 11
2023/2024268 31 13 17 11 19 99 38 5 6 10 3 16
2024/2025458 30 67 63 27 10 42 17 24 48 36 46 48
2025/20262.051 99 42 109 161 157 96 292 69 790 121 81 34
Totale 4.465